News

What if batteries were non-toxic, non-flammable, cheap, abundant, and fully recyclable? AIBN and industry partner Energy Storage Industries (ESI) are chasing this very goal thanks to a new industry collaboration supported by the National Industry PhD Program (NIPP).

Associate Professor Shyuan Ngo, or "Shu" as she is widely known, has been walking the halls of UQ since 1999. She first arrived as an undergraduate student and is now a group leader at the AIBN, where she leads research into MND. Today, with the official opening of UQ’s new Centre for MND Research, her vision for collaborative, patient-driven science is coming to life.

A newly discovered enzyme is helping scientists perform a rare chemical reaction once considered out of reach, potentially paving the way for a new generation of antibiotics, cancer therapies, and sustainable materials.

By the time Dr Cheng Zhang and his colleagues at AIBN joined CSIRO’s ON Prime program, their PFAS (per- and polyfluoroalkyl substances, or ‘forever chemicals’) sorbent was already showing promise in the lab. What they hadn’t yet figured out was how to make it matter outside of it. 

A low-cost, 3D-printed DNA testing device developed at the AIBN is making powerful science more accessible for researchers and students around the world.

Brewing dairy proteins might sound unusual, but that’s exactly what researchers at The University of Queensland’s Food and Beverage Accelerator (FaBA) have achieved, using precision fermentation to create dairy ingredients for the food and beverage sector.

A team of researchers at the AIBN, led by Dr Ruirui Qiao, have successfully patented a breakthrough tool accelerating this research and bringing regenerative medicine solutions closer to reality.

A novel cutting-edge technology is accelerating the development of next-generation cancer treatments, with AIBN now home to an AdvanCell Lead-212 generator.

Queensland is cementing its global leadership in mRNA science with the launch of a new protocol designed to make its research more accessible than ever before.

A revolutionary wound care technology developed at AIBN is a step closer to market, with the potential to save lives and transform trauma care across outback Queensland.

University of Queensland PhD student Hemanshi Galaiya has been named a 2025 Universitas 21 Leader of the Future, recognised for her work expanding access to STEM education for under-resourced students in Kenya.

Proud Gubbi Gubbi man Dr Francis McCallum from The University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) has been awarded a prestigious fellowship to advance microchip research in Japan.

A breakthrough in sustainable solar energy is moving closer to market, thanks to a new partnership between The University of Queensland (UQ) and clean technology company Halocell Energy.

Construction is underway on The University of Queensland’s new $60-million Biosustainability Hub, a state-of-the-art facility designed to accelerate the transition to a sustainable global bioeconomy.  

Researchers from the AIBN will play a key collaborative role in a national effort to revolutionise treatment options for patients with prostate cancer.

Researchers from the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology are calling for global benchmarking to fast-track PFAS research and remediation efforts.

Researchers at The University of Queensland have set a new world record efficiency for lead-free perovskite solar cells, advancing the development of safer, more sustainable solar technologies.

Researchers at the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology are working to develop a vaccine in just 100 days to support future pandemic preparedness.

AIBN Emerging Group Leader Dr Run Zhang has secured a grant from the Food and Beverage Accelerator (FaBA) to advance sensor technology that detects antibiotic residues in food, improving food safety.

University of Queensland researchers are taking up the fight against one of the deadliest forms of breast cancer, developing next-generation nanoparticles to supercharge current treatments for triple-negative breast cancer.